Literature DB >> 9951989

Visceral leishmaniasis treated with liposomal amphotericin B.

S Catania1, C Aiassa, S Tzahtzoglou, N Catania, L Tucciarone, A Antimi, G Ragni, A Clerico.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9951989     DOI： 10.1097/00006454-199901000-00021

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  2 in total

1.  US Food and Drug Administration Approval of Liposomal Amphotericin B for the Treatment of Visceral Leishmaniasis: A Model for Orphan Drug Development.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.725

2.  Leishmaniasis at the End of the Millennium.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.725
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.